Jul 28
|
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox
|
Jul 28
|
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives
|
Jul 15
|
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
|
Jul 2
|
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
|
Jun 23
|
Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply
|
Jun 5
|
Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
|
Apr 10
|
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
|
Mar 31
|
Emergent BioSolutions Announces Stock Repurchase Program
|
Mar 13
|
High Growth Tech Stocks In The US Market March 2025
|
Mar 13
|
Emergent signs financial investment agreement with Swiss Rockets
|
Mar 13
|
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
|
Mar 12
|
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
|
Mar 10
|
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
|
Feb 18
|
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
|
Dec 30
|
Why Emergent BioSolutions Stock Blasted Higher Today
|
Oct 15
|
Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata
|
Oct 14
|
3 Stocks Poised for Better Returns With New Analyst Coverage
|
Oct 11
|
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
|
Oct 9
|
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
|
Oct 9
|
Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
|